ARCHIVES

CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans.

This article is from The Cancer Letter archive.

Vol. 30 No. 42 | November 5, 2004

Download PDF Visit The Full Archive

Related Articles

Afinitor Increases Overall Survival To 3.5 Years in Phase III Trial

September 26, 2014

DCT Board Approves Concept Of Planning Grants For New Particle Therapy Equipment Development

August 7, 1981

NCI Review Groups Merged Into One Umbrella Group

November 17, 1995

Research Contract Dollars Will Drop In 1980, But Will Increase Sharply for Some Programs

July 7, 1978

In Brief: Oliverio Moves to DEA; Kushner Blass NIH Slow Pay; DeVita Welcomes Hawkin’s Probe

February 6, 1981

Toxicity Of Salts Regimen Should Remain A Concern.

January 4, 2002